PMC:7534795 / 9939-10215
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T73102","span":{"begin":71,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A18995","pred":"fma_id","subj":"T73102","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T19","span":{"begin":71,"end":76},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T87","span":{"begin":15,"end":29},"obj":"Disease"},{"id":"T88","span":{"begin":62,"end":84},"obj":"Disease"},{"id":"T89","span":{"begin":71,"end":84},"obj":"Disease"},{"id":"T90","span":{"begin":109,"end":121},"obj":"Disease"},{"id":"T91","span":{"begin":219,"end":227},"obj":"Disease"}],"attributes":[{"id":"A87","pred":"mondo_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/MONDO_0000745"},{"id":"A88","pred":"mondo_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A89","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A90","pred":"mondo_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59930","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T6034","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T53133","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T9658","span":{"begin":71,"end":76},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T77625","span":{"begin":89,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T42","span":{"begin":15,"end":29},"obj":"Phenotype"},{"id":"T43","span":{"begin":109,"end":121},"obj":"Phenotype"}],"attributes":[{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0001695"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
2_test
{"project":"2_test","denotations":[{"id":"33031856-32171076-84038823","span":{"begin":167,"end":171},"obj":"32171076"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"377","span":{"begin":96,"end":104},"obj":"Species"},{"id":"378","span":{"begin":228,"end":236},"obj":"Species"},{"id":"393","span":{"begin":15,"end":29},"obj":"Disease"},{"id":"394","span":{"begin":62,"end":84},"obj":"Disease"},{"id":"395","span":{"begin":109,"end":121},"obj":"Disease"},{"id":"396","span":{"begin":219,"end":227},"obj":"Disease"},{"id":"397","span":{"begin":253,"end":256},"obj":"Disease"}],"attributes":[{"id":"A377","pred":"tao:has_database_id","subj":"377","obj":"Tax:9606"},{"id":"A378","pred":"tao:has_database_id","subj":"378","obj":"Tax:9606"},{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"MESH:D006323"},{"id":"A394","pred":"tao:has_database_id","subj":"394","obj":"MESH:D003324"},{"id":"A395","pred":"tao:has_database_id","subj":"395","obj":"MESH:D006973"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"MESH:C000657245"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"onin levels or cardiac arrest during hospitalization, 17% had coronary heart disease and 35% of patients had hypertension (Zheng, Ma, Zhang, \u0026 Xie, 2020; Zhou et al., 2020). However, there is accumulating evidence that COVID-19 patients with underlying CVD are at higher risk "}